The effect of crosslinker, functional monomer and extraction on the long-term performance and degradation of molecularly imprinted polymers was investigated through adsorption studies, NMR, SEM, TGA and BET.

In this work we introduce a sustainable membrane-based synthesis–separation platform for enantioselective organocatalysis. An azido derivatized cinchona-squaramide bifunctional catalyst was synthesized and subsequently grafted to the surface of a polybenzimidazole-based nanofiltration membrane. The favorable effect of the covalent graftingdue to the change in geometry and increased secondary interactionson the catalytic activity due to conformational changes was confirmed by quantum chemical calculations. Asymmetric Michael and aza-Michael reactions of 1,3-dicarbonyl and indole, pyrazole, and triazole derivatives to β-nitrostyrene were performed with as high as 99% enantiomeric excess. This report on the enantioselective aza-Michael reaction of pyrazoles and triazoles opens new frontiers in the application of squaramide-based cinchona catalysts. A catalytic membrane cascade reactor was developed for an integrated synthesis–purification process allowing at least 98% product and substrate recovery, and quantitative in situ solvent recycling. The sustainability of the synthetic methodology was assessed through E-factor and carbon footprint.

Solvent usage in the pharmaceutical sector accounts for as much as 90 % of the overall mass during manufacturing processes. Consequently, solvent consumption poses significant costs and environmental burdens. Continuous processing, in particular continuous‐flow reactors, have great potential for the sustainable production of pharmaceuticals but subsequent downstream processing remains challenging. Separation processes for concentrating and purifying chemicals can account for as much as 80 % of the total manufacturing costs. In this work, a nanofiltration unit was coupled to a continuous‐flow rector for in situ solvent and reagent recycling. The nanofiltration unit is straightforward to implement and simple to control during continuous operation. The hybrid process operated continuously over six weeks, recycling about 90 % of the solvent and reagent. Consequently, the E‐factor and the carbon footprint were reduced by 91 % and 19 %, respectively. Moreover, the nanofiltration unit led to a solution of the product eleven times more concentrated than the reaction mixture and increased the purity from 52.4 % to 91.5 %. The boundaries for process conditions were investigated to facilitate implementation of the methodology by the pharmaceutical sector.

No abstract